Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-21

FDA Approved: CARVEDILOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark Pharmaceuticals' supplemental application for carvedilol, clearing a generic formulation for regulatory sale. This marks an approval o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)